Cargando…
Comparison of two peptide radiotracers for prostate carcinoma targeting
OBJECTIVES: Scintigraphy is generally not the first choice treatment for prostate cancer, although successful studies using bombesin analog radiopeptides have been performed. Recently, a novel peptide obtained using a phage display library demonstrated an affinity for prostate tumor cells. The aim o...
Autores principales: | Faintuch, Bluma Linkowski, Oliveira, Erica A, Nunez, Eutimio G F, Moro, Ana M, Nanda, P K, Smith, Charles J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275116/ https://www.ncbi.nlm.nih.gov/pubmed/22358242 http://dx.doi.org/10.6061/clinics/2012(02)12 |
Ejemplares similares
-
Radiolabeled nano‐peptides show specificity for an animal model of human PC3 prostate cancer cells
por: Faintuch, Bluma Linkowski, et al.
Publicado: (2011) -
Functional investigation of bone implant viability using radiotracers in a new model of osteonecrosis
por: Schiper, Luis, et al.
Publicado: (2016) -
Computer-Assisted Design of Peptide-Based Radiotracers
por: Patamia, Vincenzo, et al.
Publicado: (2023) -
Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging
por: Shi, Jiyun, et al.
Publicado: (2016) -
Nuclear Medicine in Prostate Cancer: A New Era for Radiotracers
por: Cuccurullo, Vincenzo, et al.
Publicado: (2018)